Casein-based formulations as promising controlled release drug delivery systems.
about
Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cellsLayer-by-layer assembled milk protein coated magnetic nanoparticle enabled oral drug delivery with high stability in stomach and enzyme-responsive release in small intestine.Protective role of ascorbic acid in the decontamination of cow milk casein by gamma-irradiation.Synthesis, cellular uptake, and biodistribution of whey-rich nanoparticles.Casein maps: effect of ethanol, pH, temperature, and CaCl2 on the particle size of reconstituted casein micelles.Translation attenuation via 3' terminal codon usage in bovine csn1s2 is responsible for the difference in αs2- and β-casein profile in milk.Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering.Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics.Natural proteins: Sources, isolation, characterization and applicationsDiverse Applications of Nanomedicine.Review: Milk Proteins as Nanocarrier Systems for Hydrophobic Nutraceuticals.Theranostic potential of gold nanoparticle-protein agglomerates.Coated biodegradable casein nanospheres: a valuable tool for oral drug delivery.Biological Evaluation of a New Synthesized Pt(II) Complex by Cytotoxic and Spectroscopic Studies.Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems.Keratin: dissolution, extraction and biomedical application.Potential of Casein as a Carrier for Biologically Active Agents.Amelioration of Diabetes and Painful Diabetic Neuropathy by Punica granatum L. Extract and Its Spray Dried Biopolymeric Dispersions.Validation of therapeutic anti-inflammatory potential of Arjuna Ksheera Paka - A traditional Ayurvedic formulation of Terminalia arjunaPseudomonas sp. as a Source of Medium Chain Length Polyhydroxyalkanoates for Controlled Drug Delivery: Perspective.Aggregation-induced emission of 1,8-naphthalimide-casein micelle: investigation by synchronous spectrographic method.Micellar delivery of flutamide via milk protein nanovehicles enhances its anti-tumor efficacy in androgen-dependent prostate cancer rat model.Novel spray-dried genipin-crosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride.Flavonoid-based pH-responsive hydrogels as carrier of unstable drugs in oxidative conditions.Casein-based micelles: a novel vector for delivery of the poorly soluble anticancer drug, flutamide?Structure, gelation, and antioxidant properties of curcumin-doped casein micelle powder produced by spray-drying.Milk caseins as useful vehicle for delivery of dipyridamole drug.Soy protein isolate as a nanocarrier for enhanced water dispersibility, stability and bioaccessibility of β-carotene.Targeting intracellular MMPs efficiently inhibits tumor metastasis and angiogenesis.Polymeric nanoparticles for food applicationsNew Trends in the Microencapsulation of Functional Fatty Acid-Rich Oils Using Transglutaminase Catalyzed CrosslinkingMilk Proteins: Drug Delivery SystemsIncreased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein NanoparticlesNovel anti-inflammatory film as a delivery system for the external medication with bioactive phytochemical "Apocynin"
P2860
Q28544700-3605F277-7A68-45AD-AC86-14BA56CA6220Q30874627-EBEB38EC-DB0A-4093-99F8-386ED5F9F0F7Q34567395-0EE53F20-0F05-4608-B077-383762A4E3A5Q35161889-CD6B526D-5EF1-4F45-935F-81CA15B84680Q36024843-20371619-8BB3-4797-90CD-515EDA5C2BD9Q36189968-FED2758E-2B4A-4B73-8CC6-A2BF4B2E703CQ36590092-BB4DF756-A6CC-4A51-A597-22F2617CD7ADQ36825267-1F7C5A13-151A-4C14-A5FF-9CDE9E150ABAQ37346506-F1DDAE39-75FA-411E-8E0F-61785E99A1CEQ37728142-1DA5D49D-B131-4151-8CB9-EB90CC76F930Q38607282-5C6B1F5A-1947-4D3D-98D7-54E7D8486AE5Q38617939-8E68EC7E-B396-4D1F-B2F0-085CD708913FQ38869649-B1ADEF59-00D8-48F9-B2EA-BB6A0F83B341Q38939929-2A83DDFF-6F0B-44C9-9390-5F35F35830A3Q39257007-4C4ACB5C-E030-42E5-86C1-B877090BADEEQ39420821-BD05393E-03F6-4F4A-8766-0CB44E835087Q39437367-72D59852-5895-43BD-BAC6-037D05E3E646Q40734719-CF0DFA52-E577-40BD-9550-D60D7137BCEFQ42374020-EB1F4926-B5CA-4EAB-9FA7-22623B4CE14EQ42588729-D6EB2D99-CDA9-4CF2-8E54-BEE6C9F0595DQ43499617-6959CDAC-3FA4-4346-A81A-6597CA2FBB4FQ43700837-88A0A4F5-5207-4643-A6C7-1AD2F3945177Q44977170-DE6E6F52-17D6-4D1C-927B-17E36BEEFB55Q45387249-AA5441AB-1CE1-4E6A-88CB-B3DD357F279AQ46576152-3ADAF74A-3B39-449C-8C0F-B277D556B302Q47721983-8409A22D-F8C4-4E41-85B0-9AB22A39E850Q50994218-088E1DF2-4D64-4020-B1D3-9AF40522A8FDQ51167205-A1EB8749-9228-423E-9D9B-1AED7ACB82ABQ55531515-C22D3862-49D5-4784-BCDA-F0FE73801C2AQ57340451-A2054D45-D37C-4F60-8838-95D85713F68BQ57828591-D1FEE482-9FF1-4210-88CD-778848A8A8ECQ58325910-9FBD1B3C-E851-4CA5-883D-03E29CFA0B71Q58723030-33254192-7779-46EE-9722-FDCC5F015950Q58743360-0263CEA8-5BCD-4012-83B8-07880617B3A6
P2860
Casein-based formulations as promising controlled release drug delivery systems.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Casein-based formulations as promising controlled release drug delivery systems.
@en
Casein-based formulations as promising controlled release drug delivery systems.
@nl
type
label
Casein-based formulations as promising controlled release drug delivery systems.
@en
Casein-based formulations as promising controlled release drug delivery systems.
@nl
prefLabel
Casein-based formulations as promising controlled release drug delivery systems.
@en
Casein-based formulations as promising controlled release drug delivery systems.
@nl
P1476
Casein-based formulations as promising controlled release drug delivery systems
@en
P2093
Nazik A Elgindy
Wael S Abo El-Fotoh
P304
P356
10.1016/J.JCONREL.2011.02.010
P407
P577
2011-02-19T00:00:00Z